0001104659-22-026109.txt : 20220223 0001104659-22-026109.hdr.sgml : 20220223 20220223162038 ACCESSION NUMBER: 0001104659-22-026109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220219 FILED AS OF DATE: 20220223 DATE AS OF CHANGE: 20220223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NEWHALL CHARLES W III CENTRAL INDEX KEY: 0001005544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 22663996 MAIL ADDRESS: STREET 1: 1119 ST PAUL ST CITY: BALTIMORE STATE: MD ZIP: 21202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4 1 tm227492-5_4seq.xml OWNERSHIP DOCUMENT X0306 4 2022-02-19 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001005544 NEWHALL CHARLES W III C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 1 0 0 0 Common Stock 2022-02-19 4 A 0 4222 0 A 101731 D Restricted Stock Units 2022-02-19 4 D 0 4222 0 D Common Stock 4222 0 D Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022. /s/ Jack A. Khattar, as attorney-in-fact 2022-02-23